Acute toxicity and withdrawal syndromes related to gamma‐hydroxybutyrate (GHB) and its analogues gamma‐butyrolactone (GBL) and 1,4‐butanediol (1,4‐BD)
- 6 May 2011
- journal article
- review article
- Published by Wiley in Drug Testing and Analysis
- Vol. 3 (7-8) , 417-425
Abstract
Gamma‐hydroxybutyrate (GHB) has been used as a recreational drug since the 1990s and over the last few years there has been increasing use of its analogues gamma‐butyrolactone (GBL) and to a lesser extent 1,4‐butanediol (1,4BD). This review will summarize the literature on the pharmacology of these compounds; the patterns and management of acute toxicity associated with their use; and the clinical patterns of presentation and management of chronic dependency associated with GHB and its analogues. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 106 references indexed in Scilit:
- The first reported UK fatality related to gamma-butyrolactone (GBL) ingestionJournal of the Royal Society of Medicine, 2009
- Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboonsPsychopharmacology, 2009
- Behavioral analyses of GHB: Receptor mechanismsPharmacology & Therapeutics, 2009
- Baclofen and Gamma-Hydroxybutyrate WithdrawalNeurocritical Care, 2008
- Experiences of Gamma Hydroxybutyrate (GHB) Ingestion: A Focus Group StudyJournal of Psychoactive Drugs, 2007
- High-Risk Behaviors and Hospitalizations Among Gamma Hydroxybutyrate (GHB) UsersThe American Journal of Drug and Alcohol Abuse, 2007
- Gamma-hydroxybutyrate and Ethanol Effects and Interactions in HumansJournal of Clinical Psychopharmacology, 2006
- Seven Days of Gamma-Hydroxybutyrate (GHB) Use Produces Severe WithdrawalAnnals of Emergency Medicine, 2006
- High affinity binding site for γ-hydroxybutyric acid in rat brainLife Sciences, 1982
- Sodium 4-hydroxybutyrateInternational Journal of Neuropharmacology, 1964